Global Cystic Fibrosis Therapeutics Market 2018-2022

Overview of the global cystic fibrosis therapeutics market

Several diagnostic tests are conducted to detect genetically inherited cystic fibrosis (CF) disease. Some of the recommended diagnosis tests are antenatal testing, carrier testing, and other tests such as genetic tests and sweat tests. The increasing awareness and high investment will enhance the diagnostic technologies and ease the detection of such genetic diseases. Technavio’s market research report has identified improved diagnostic technologies as one of the primary factors that will trigger the growth of the cystic fibrosis therapeutics market in the next five years.

Get A Free Sample 

In the recent times, several advanced diagnostic methods are adopted for detecting cystic fibrosis. For example, DNA test for comprehensive and accurate screening of newborns for CF involves next generation DNA sequencing which helps in detecting the entire CFTR gene. Moreover, this method is less time-consuming. Our market research analysts estimate the cystic fibrosis therapeutics market to grow steadily at a CAGR more than 17% by 2022.

The growing strategic collaboration is one of the key trends contributing towards the growth of the cystic fibrosis (CF) therapeutics market. Companies are extensively entering into M&A to increase the market penetration and improve the company’s product portfolio. This process significantly contributes to symbiotic relation among the companies as the companies exchange their technical expertise and ensures sufficient funds for R&D. To increase the global footprint, the vendors are focusing on making acquisition strategies and expand the product line.

Cystic fibrosis market report: Companies covered:

The cystic fibrosis diagnosis market is fragmented due to the presence of several players. This industry research report provides a detailed information of the competitive environment among the players in this market space. Moreover, our analysts also provide strategies and areas that the vendors should follow to improve their market shares and sustain the competitive environment in the cystic fibrosis therapeutics market.

According to our market research experts, the following are some of the companies in the cystic fibrosis therapeutics market.

• AbbVie
• Gilead
• F. Hoffmann-La Roche
• Vertex Pharmaceuticals

Geographical segmentation and analysis of the cystic fibrosis therapeutics market

• Americas
• APAC
• EMEA

This market study estimates that in terms of geographic regions, the Americas will be the major revenue contributor to the cystic fibrosis (CF) therapeutics market throughout the forecast period. This region is expected to witness significant growth during the forecast period due to the high investments in the healthcare sector by the economic giants.

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.   

Key questions answered in the report include

• What will the cystic fibrosis therapeutics market size and the growth rate be in 2022?
• What are the key factors driving the global cystic fibrosis therapeutics market?
• What are the key market trends impacting the growth of the global cystic fibrosis therapeutics market?
• What are the challenges to market growth?
• Who are the key vendors in the global cystic fibrosis therapeutics market?
• What are the market opportunities and threats faced by the vendors in the global cystic fibrosis therapeutics market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global cystic fibrosis therapeutics market?

Technavio also offers customization on reports based on specific client requirement.